Good afternoon, good people, Ohm, you raise the ultimate

New Post Public Reply Private Reply Replies (0) Message Board
TSOV ohm20 #91307
772
Good afternoon, good people,

Ohm, you raise the ultimate question that can be asked of this entire fiasco called "FDA management and response of and to COVID-19". To wit: "if ordinary citizens don't hold the government accountable then who will?"

This is the ONLY question that matters at the moment- to shareholders, citizens of the United States, and suffering patients of COVID-19 the world over. Most everyone following Cytodyn and LL by now 'knows' 3 key pieces of information that are as irrefutable as irrefutable can get:

1. The drug is extremely safe and poses little to no harm
2. The drug has shown "benefit" in a particulary vulnerable subset of critical COVID-19 patients whom for which there is currently NO AVAILABLE approved therapeutic ANYWHERE
3. The FDA did NOT allow a 4 dose regimen as the company and its medical officers REQUESTED and was instead guided to an allowed only a 2 dose regimen that ended at day 14. Gilead and Lilly suffered no such restrictions that the public has been made aware of

These 3 pieces of information are not just damning to the ongoing credibility of the FDA but call into question whether or not the FDA has committed malfeasance. This term (malfeasance) is not one I use lightly but 'if the cap fits, then let them wear it'. (Hat tip The Legend, Bob Marley)

Therefore, Ohm, your question is THE question.

A wise man once said, if you want to get to the bottom of things "follow the money". Look who benefitted from keeping LL off the market. Then, look who agented that action. The FDA made no such effort to rebuke or reprise the makers of hydroxychloroquine, nor companies such a Gilead nor Eli Lilly, whose drugs proved woefully ineffectual and in some cases proved injurious to those taking them. This leads to one undeniable conclusion: the FDA is (has been) severely compromised during this year and half sojourn in all matters COVID-19. By whom and for whom is not my concern, the point is the agency can no longer be trusted to do its job. Our government is built on a series of checks and balances, with the ultimate check being the people and our right to vote and discuss amongst ourselves FREELY via our FREE speech within FREE assembly or within a FREE PRESS.

Let us for the sake of argument (of which this board heavily traffics) posit that via kleptocracy or sheer regulatory capture the FDA no longer suffers under the burdens of normal constitutional checks and balances, then what relief if any does Cytodyn and LL have?

Good people, let me share with you the marvel of 21st century Ameican style unfettered capitalism's most ingenious if not corrosive product: The Market.

The Market is our ultimate salve and imho the answer to Ohm's ultimate question. We are a public company whose shares are everyday FOR SALE on the open market even if our only product is not. This morning we learn that Pfizer and ...drumroll please ... AstraZenca's vaccines have proven effective against the Indian strain of COVID-19. This is a SIGNIFICANT development because we now have the possible entrant of a NON US BASED behemoth of a rival to the 2 US based duopolists of the SOC COVID-19 vaccination. Will Astra Zenca sit idly by and watch the defecto primary COVID-19 theraputic go unexploited? Will Merck sit idly and dump billions more into R&D while batting .000 thus far in the great game of International COVID-19 moneyball???

Our Top Line CD12 report is now public record.
This came AFTER the FDA's public puke on Cytodyn.

Imho, the only question that really remains after this last week and this morning's India AstraZeneca news is "how much?" and is that in "cash or stock"?

The FDA is big, yes but no entity, not even sovereign nations, are bigger than The Market.

The FDA has signaled to the entire table just how weak a hand they have had and it's my opinion that weak play is ALWAYS punished. That's why billionaires are billionaires and why bureaucrats are bureaucrats and why politicians tend to remain politicians. Water finds its appropriate level, much like talent in The Market.

TSOV
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Transforms Syngenta's Tech Core to Boost Agility

Updated Category News Views 227

Unpacking the Syngenta-Infosys Transformation Forget your run-of-the-mill tech upgrade; Infosys has just spearheaded a massive transformation for Syngenta, delivering a new global SAP S/4HANA setup that’s set to turbocharge their Crop Protection business. We’re talking about more than just another software upgrade here—this is a sweeping overhaul affecting 10,000...

Continue Reading
Backroads Invites Families: Adventures Boost Bookings by 20%

Updated Category News Views 118

Rediscovering Family Time Through Adventure When was the last time a winter vacation got you this fired up? Backroads, the trailblazer in active getaways, is bucking the trend of typical holiday madness. Families are ditching the usual gift-giving grind for something way more memorable: experiences that blend action with bonding across generations. Big Numbers, Big...

Continue Reading
Elbit Systems Poised for Q3 2026 Earnings Reveal

Updated Category News Views 17

Elbit Systems: A Strategic Player in Defense Here's what's going on with Elbit Systems Ltd. (NASDAQ:ESLT), the Israeli defense heavy hitter. They're gearing up to spill the beans on their Q3 financial results this November 17th. And for those of us keeping an eye on how defense contractors are adapting to today's chaotic geopolitical climate, this is a date you don't want...

Continue Reading
Experts Unite to Tackle Drowsy Driving at NSF Forum

Updated Category News Views 76

Awareness With a Purpose Heads-up, folks: the National Sleep Foundation's bringing the cavalry on drowsy driving to Washington. It's almost surreal how often we ignore the sleepy-eyed driver next to us, isn't it? Yet, here we are, revving up for a gathering where they're gathering the nation's sharpest minds in sleep science and traffic safety under one roof. Why Drowsy...

Continue Reading
Epilepsy Market's Explosive Growth Forecasted to 2036

Updated Category News Views 69

It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...

Continue Reading
Peloton Broker: Streamlining Energy Land Deals

Updated Category News Views 41

Peloton's New Broker Tool: What Miners and Developers Should Know Here's one for the energy folk who are up to their ears in land titles and lease talk. Peloton just threw a wrench in the scattered land data mess with Peloton Broker. Think of it as the 'new kid on the block' in their Land Data Management solution, designed to untangle the madness that often clogs the...

Continue Reading
Political Jitters Push US Investors to Golden Visas

Updated Category News Views 98

Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...

Continue Reading
Celebrating Leaders Advancing Type 1 Diabetes Research

Updated Category News Views 47

Honoring Trailblazers in Type 1 Diabetes Research It's not every day that we get to shine a spotlight on the unsung heroes in the field of Type 1 Diabetes (T1D) research. Today, we pause to celebrate those who are doing the heavy lifting to make the lives of millions better. Breakthrough T1D, the name says it all, presented its prestigious awards to four titans of...

Continue Reading
Ad Council Expands Board, Taps Meta Exec as Vice Chair

Updated Category News Views 55

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

Continue Reading
U.S. Gold Corp. Gears Up for Key October Event

Updated Category News Views 30

Marking Calendars for the Emerging Growth Showdown There's nothing quite like the buzz leading up to an event where you know someone’s either gonna make a splash or barely leave a ripple. U.S. Gold Corp. is drawing some attention ahead of the Emerging Growth Conference on October 29, 2026. This ain't just any corporate dog-and-pony show—it's a chance for the Gold...

Continue Reading

Top 5 Most Recently Viewed Articles

AECI Utility Solutions Expands with New Distribution Center

Updated Category News Views 183

AECI Utility Solutions Expands with New Distribution Center AECI Utility Solutions has selected Boonville for a major expansion, establishing a new distribution center. This facility will not only increase operational efficiency but also enhance service to electric cooperatives in the area. Facility Overview This new distribution center will span approximately 50,000...

Continue Reading
Market Update: U.S. Stocks React to Economic Growth Data

Updated Category News Views 81

U.S. Stock Market Performance The U.S. stock market displayed a mixed performance recently, with the Nasdaq Composite reporting a slight gain of around 0.2%. The market opened on a relatively flat note, with the Dow Jones Industrial Average experiencing a minor dip of 0.01%, reflecting a level of cautious trading among investors. Key Indices Movement Dow and S&P 500...

Continue Reading
New Affordable Housing Units Open to Support Seniors' Needs

Updated Category News Views 169

Celebrating the Inauguration of New Affordable Housing Units The local community recently celebrated the opening of 10 new social and affordable housing units designed to assist semi-independent seniors. This significant project is an essential step towards addressing the housing needs of our aging population, allowing them to live more comfortably and safely. Investment...

Continue Reading
Power Solutions International's Remarkable Financial Performance

Updated Category News Views 214

Power Solutions International Reports Impressive Financial Results Power Solutions International, Inc. (Nasdaq: PSIX), a prominent player in the development and manufacturing of emission-certified engines and power systems, has witnessed substantial growth, culminating in record financial results for the fourth quarter and the entire year. The company reported quarterly...

Continue Reading
IEHP Responds to DOJ Filing with Strong Defense Commitments

Updated Category News Views 403

Inland Empire Health Plan's Response to DOJ Allegations Inland Empire Health Plan (IEHP) has recently become aware of a significant filing by the United States Department of Justice. This filing alleges that the organization violated the False Claims Act. However, IEHP has communicated a strong disagreement with these claims and is dedicated to vigorously defending itself...

Continue Reading